vs
Progyny, Inc.（PGNY）与Pennant Group, Inc.（PNTG）财务数据对比。点击上方公司名可切换其他公司
Progyny, Inc.的季度营收约是Pennant Group, Inc.的1.1倍（$318.4M vs $289.3M），Progyny, Inc.净利率更高（3.9% vs 3.0%，领先0.9%），Pennant Group, Inc.同比增速更快（53.2% vs 6.7%），Progyny, Inc.自由现金流更多（$48.6M vs $17.4M），过去两年Pennant Group, Inc.的营收复合增速更高（35.8% vs 7.0%）
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
Pennant Group, Inc.是一家总部位于美国的医疗服务企业，主营家庭健康护理、临终关怀、长者居住服务及专业护理服务，业务覆盖美国数十个州，核心服务对象为老年及有特殊医疗需求的弱势人群。
PGNY vs PNTG — 直观对比
营收规模更大
PGNY
是对方的1.1倍
$289.3M
营收增速更快
PNTG
高出46.5%
6.7%
净利率更高
PGNY
高出0.9%
3.0%
自由现金流更多
PGNY
多$31.2M
$17.4M
两年增速更快
PNTG
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $318.4M | $289.3M |
| 净利润 | $12.5M | $8.6M |
| 毛利率 | 24.1% | — |
| 营业利润率 | 4.8% | 6.0% |
| 净利率 | 3.9% | 3.0% |
| 营收同比 | 6.7% | 53.2% |
| 净利润同比 | 18.5% | 50.0% |
| 每股收益（稀释后） | $0.14 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PGNYPNTG
| Q4 25 | $318.4M | $289.3M | ||
| Q3 25 | $313.3M | $229.0M | ||
| Q2 25 | $332.9M | $219.5M | ||
| Q1 25 | $324.0M | $209.8M | ||
| Q4 24 | $298.4M | $188.9M | ||
| Q3 24 | $286.6M | $180.7M | ||
| Q2 24 | $304.1M | $168.7M | ||
| Q1 24 | $278.1M | $156.9M |
净利润PGNYPNTG
| Q4 25 | $12.5M | $8.6M | ||
| Q3 25 | $13.9M | $6.1M | ||
| Q2 25 | $17.1M | $7.1M | ||
| Q1 25 | $15.1M | $7.8M | ||
| Q4 24 | $10.5M | $5.8M | ||
| Q3 24 | $10.4M | $6.2M | ||
| Q2 24 | $16.5M | $5.7M | ||
| Q1 24 | $16.9M | $4.9M |
毛利率PGNYPNTG
| Q4 25 | 24.1% | — | ||
| Q3 25 | 23.2% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 23.4% | — | ||
| Q4 24 | 21.3% | — | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 22.4% | — |
营业利润率PGNYPNTG
| Q4 25 | 4.8% | 6.0% | ||
| Q3 25 | 6.9% | 4.5% | ||
| Q2 25 | 7.3% | 5.3% | ||
| Q1 25 | 7.5% | 6.0% | ||
| Q4 24 | 5.3% | 4.9% | ||
| Q3 24 | 4.3% | 6.0% | ||
| Q2 24 | 6.8% | 5.7% | ||
| Q1 24 | 6.7% | 5.4% |
净利率PGNYPNTG
| Q4 25 | 3.9% | 3.0% | ||
| Q3 25 | 4.4% | 2.7% | ||
| Q2 25 | 5.1% | 3.2% | ||
| Q1 25 | 4.6% | 3.7% | ||
| Q4 24 | 3.5% | 3.0% | ||
| Q3 24 | 3.6% | 3.4% | ||
| Q2 24 | 5.4% | 3.4% | ||
| Q1 24 | 6.1% | 3.1% |
每股收益（稀释后）PGNYPNTG
| Q4 25 | $0.14 | $0.25 | ||
| Q3 25 | $0.15 | $0.17 | ||
| Q2 25 | $0.19 | $0.20 | ||
| Q1 25 | $0.17 | $0.22 | ||
| Q4 24 | $0.12 | $0.16 | ||
| Q3 24 | $0.11 | $0.20 | ||
| Q2 24 | $0.17 | $0.18 | ||
| Q1 24 | $0.17 | $0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.2M | — |
| 总债务越低越好 | — | $168.8M |
| 股东权益账面价值 | $516.0M | $374.3M |
| 总资产 | $742.4M | $968.2M |
| 负债/权益比越低杠杆越低 | — | 0.45× |
8季度趋势，按日历期对齐
现金及短期投资PGNYPNTG
| Q4 25 | $112.2M | — | ||
| Q3 25 | $134.0M | — | ||
| Q2 25 | $132.5M | — | ||
| Q1 25 | $109.2M | — | ||
| Q4 24 | $162.3M | — | ||
| Q3 24 | $91.5M | — | ||
| Q2 24 | $95.0M | — | ||
| Q1 24 | $115.0M | — |
总债务PGNYPNTG
| Q4 25 | — | $168.8M | ||
| Q3 25 | — | $26.0M | ||
| Q2 25 | — | $37.0M | ||
| Q1 25 | — | $52.5M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $108.9M | ||
| Q2 24 | — | $82.2M | ||
| Q1 24 | — | $83.3M |
股东权益PGNYPNTG
| Q4 25 | $516.0M | $374.3M | ||
| Q3 25 | $560.0M | $343.0M | ||
| Q2 25 | $515.0M | $333.6M | ||
| Q1 25 | $467.2M | $323.0M | ||
| Q4 24 | $422.1M | $312.0M | ||
| Q3 24 | $434.9M | $187.3M | ||
| Q2 24 | $456.2M | $173.0M | ||
| Q1 24 | $571.6M | $164.2M |
总资产PGNYPNTG
| Q4 25 | $742.4M | $968.2M | ||
| Q3 25 | $795.2M | $753.6M | ||
| Q2 25 | $761.0M | $751.4M | ||
| Q1 25 | $730.3M | $743.6M | ||
| Q4 24 | $607.1M | $679.5M | ||
| Q3 24 | $660.0M | $646.8M | ||
| Q2 24 | $698.6M | $602.5M | ||
| Q1 24 | $794.3M | $578.2M |
负债/权益比PGNYPNTG
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.48× | ||
| Q1 24 | — | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.2M | $21.0M |
| 自由现金流经营现金流 - 资本支出 | $48.6M | $17.4M |
| 自由现金流率自由现金流/营收 | 15.3% | 6.0% |
| 资本支出强度资本支出/营收 | 1.8% | 1.2% |
| 现金转化率经营现金流/净利润 | 4.34× | 2.43× |
| 过去12个月自由现金流最近4个季度 | $191.8M | $36.3M |
8季度趋势，按日历期对齐
经营现金流PGNYPNTG
| Q4 25 | $54.2M | $21.0M | ||
| Q3 25 | $50.7M | $13.9M | ||
| Q2 25 | $55.5M | $34.6M | ||
| Q1 25 | $49.8M | $-21.2M | ||
| Q4 24 | $52.2M | $20.6M | ||
| Q3 24 | $44.5M | $7.7M | ||
| Q2 24 | $56.7M | $10.5M | ||
| Q1 24 | $25.7M | $545.0K |
自由现金流PGNYPNTG
| Q4 25 | $48.6M | $17.4M | ||
| Q3 25 | $46.0M | $10.5M | ||
| Q2 25 | $50.2M | $31.6M | ||
| Q1 25 | $47.0M | $-23.2M | ||
| Q4 24 | $50.3M | $17.2M | ||
| Q3 24 | $42.7M | $6.8M | ||
| Q2 24 | $55.8M | $8.9M | ||
| Q1 24 | $24.9M | $-2.6M |
自由现金流率PGNYPNTG
| Q4 25 | 15.3% | 6.0% | ||
| Q3 25 | 14.7% | 4.6% | ||
| Q2 25 | 15.1% | 14.4% | ||
| Q1 25 | 14.5% | -11.1% | ||
| Q4 24 | 16.8% | 9.1% | ||
| Q3 24 | 14.9% | 3.8% | ||
| Q2 24 | 18.4% | 5.3% | ||
| Q1 24 | 8.9% | -1.7% |
资本支出强度PGNYPNTG
| Q4 25 | 1.8% | 1.2% | ||
| Q3 25 | 1.5% | 1.5% | ||
| Q2 25 | 1.6% | 1.4% | ||
| Q1 25 | 0.9% | 0.9% | ||
| Q4 24 | 0.6% | 1.8% | ||
| Q3 24 | 0.6% | 0.5% | ||
| Q2 24 | 0.3% | 1.0% | ||
| Q1 24 | 0.3% | 2.0% |
现金转化率PGNYPNTG
| Q4 25 | 4.34× | 2.43× | ||
| Q3 25 | 3.65× | 2.29× | ||
| Q2 25 | 3.24× | 4.89× | ||
| Q1 25 | 3.31× | -2.73× | ||
| Q4 24 | 4.95× | 3.57× | ||
| Q3 24 | 4.27× | 1.24× | ||
| Q2 24 | 3.44× | 1.84× | ||
| Q1 24 | 1.52× | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |
